Microdissected targets histologically classified with dysplasia had the highest frequency of mutations at 17p (TP53), with mutations present in 14/16 (88%) HGD targets, 27/39 (69%) LGD targets, and 49/138 (36%) “indefinite for dysplasia” targets. Here, TP53 is linked to dysplasia.